While our bioinformatics analysis demonstrated that BMP2 transcriptional alterations correlated significantly with tumor metastasis, immune cell infiltration, and poor survival in patients with breast cancer, there still exists a substantial gap between genetic findings and experimental validation. This evidence concerns the gene BMP2 and breast carcinoma.